Ari Silverman, Healthcare Investor and Business Builder at MAVIE Technologies, has extensive experience in company/product growth strategies, commercial operations transformations, digital strategies, government collaboration, and talent and leadership development.
Josep Maria Martorell, Associate Director of the Barcelona Supercomputing Center, served as director general for Research for the Government of Catalonia from 2011 to 2016. He is currently an associate professor at the UPC Image Processing and Multimedia Technology Center and an advisor to several technology companies. He graduated in Physics at the University of Barcelona and in General Management at IESE and he also has a PhD in Computer Engineering from the University Ramon Llull.
Inma Valle worked as Independent Advisor and Investor in the Biotechnology sector. She was Investment Manager at Caixa Capital Risc, venture arm of La Caixa, were she lead more than 10 investments in the Life Sciences Sector and sat as Board Member at 4 biotechnology companies. Previously, she spent 4 years working as a researcher at the Diabetes Center at UCSF, where she focused on central regulation of metabolic disorders (obesity, type 2 diabetes, etc). She holds a PhD in Biochemistry & Molecular Biology from University Autónoma of Madrid, and a Master in Biotechnology Management with a focus on healthcare from IE Business School.
Jose Antonio is the Chief Investment Officer at Caixa Capital Risc. He specializes in investment in drug development and medical devices. He currently serves on the Board of Directors at Medlumics, Stat Diagnostica, Laboratoris Sanifit, Genmedica and nLife Therapeutics. He is responsible for the analysis, negotiation and structuring of processes in life science companies. Jose A. has more than 10 years of experience in the analysis of investment opportunities and specializes in the creation and early health sector companies. His experience began in the Department of Business Development at Genzyme Corporation, a company specializing in the development and sale of drugs for orphan diseases. He later joined the Technology Portfolio team at Genoma España, a public sector foundation that promotes technology development, knowledge transfer and innovation in the biotechnology sector. Jose Antonio holds a degree in Biology (Genetics) and a Masters in Corporate Finance from the U. Complutense, Madrid (UCM), MBA and PDD from IESE.
Clara Campàs-Moya holds a PhD in Pharmacy by the Universitat de Barcelona. She recently joined Kern Pharma SL as Strategy & Development Director were she coordinates the following departments: R&D, innovation, business development and regulatory affairs. Formerly, she worked at Advancell, SA as Managing Director and Drug development Director, as well as a Researcher at Hospital del Mar. She is the co-author of the patent Acadesine, the first drug originated in a Spanish public University that successfully reached clinical trials. She is member of the scientific committee of the venture capital fund HealthEquity, VicePresident of CataloniaBIO and member of the board of trustees of Biocat, as well as member of the scientific committee of the MIHealth Forum.
Javier Megias is an entrepreneur and investor passionate about innovation and entrepreneurship. He is currently the CEO of STARTUPXPLORE (http://startupxplore.com), a global startup and investor community he founded with a mission: to disrupt the traditional approach to startup-investment growth and to foster transparency and openness in the startup ecosystem. For the past 5 years he has been advising and acting as a board member on several organizations, ranging from startups and VC funds to institutions like the European Commission. He is also an active business angel investor, and is member of the Big BAN board, the largest independent angel investor network in Spain. Javier also writes on the blog http://javiermegias.com/blog, winner of the 2011 award to the best business Spanish-speaking blog of the world.
Marcel is an economist with more than 18 years of experience in business management, also in financial advisory and asset management. Founding partner of Future Companies, a strategic consulting specialized in growth and investment. Future Companies partners with Crea Inversion an M&A company placed in Pamplona, with offices in Madrid and Barcelona. Marcel’s experience includes incubation and acceleration programs, management of SME, mentoring in spin-offs and start-ups, and the complete process to find investment for growing companies. He has participated in different kinds of corporate processes, including mergers and creation of investment funds. In his portfolio of clients and experience there are several healthcare companies. He has led several companies in investment and professional services sectors, and currently is partner in some of them as Imacity or GuinotPrunera. He’s member of the Advisory Board of the Catalan Institute of Finance. He was General Manager of Economic Promotion of the Generalitat de Catalunya, where he promoted the creation of several financial vehicles.